- Home
- PAVS vs ABOS Comparison
PAVS vs ABOS Comparison
Compare PAVS & ABOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PAVS
- ABOS
- Stock Information
- Founded
- PAVS 2004
- ABOS 1996
- Country
- PAVS United States
- ABOS United States
- Employees
- PAVS N/A
- ABOS N/A
- Industry
- PAVS Medicinal Chemicals and Botanical Products
- ABOS Biotechnology: Pharmaceutical Preparations
- Sector
- PAVS Health Care
- ABOS Health Care
- Exchange
- PAVS Nasdaq
- ABOS Nasdaq
- Market Cap
- PAVS 90.2M
- ABOS 83.5M
- IPO Year
- PAVS 2019
- ABOS 2021
- Fundamental
- Price
- PAVS $1.37
- ABOS $1.39
- Analyst Decision
- PAVS
- ABOS Strong Buy
- Analyst Count
- PAVS 0
- ABOS 3
- Target Price
- PAVS N/A
- ABOS $9.33
- AVG Volume (30 Days)
- PAVS 6.3K
- ABOS 232.9K
- Earning Date
- PAVS 01-01-0001
- ABOS 03-25-2025
- Dividend Yield
- PAVS N/A
- ABOS N/A
- EPS Growth
- PAVS N/A
- ABOS N/A
- EPS
- PAVS N/A
- ABOS N/A
- Revenue
- PAVS $6,544,819.00
- ABOS N/A
- Revenue This Year
- PAVS N/A
- ABOS N/A
- Revenue Next Year
- PAVS N/A
- ABOS N/A
- P/E Ratio
- PAVS N/A
- ABOS N/A
- Revenue Growth
- PAVS N/A
- ABOS N/A
- 52 Week Low
- PAVS $0.32
- ABOS $1.28
- 52 Week High
- PAVS $2.44
- ABOS $5.09
- Technical
- Relative Strength Index (RSI)
- PAVS 56.35
- ABOS 37.15
- Support Level
- PAVS $1.31
- ABOS $1.36
- Resistance Level
- PAVS $1.43
- ABOS $1.52
- Average True Range (ATR)
- PAVS 0.05
- ABOS 0.08
- MACD
- PAVS -0.01
- ABOS 0.01
- Stochastic Oscillator
- PAVS 42.86
- ABOS 40.30
About PAVS Paranovus Entertainment Technology Ltd.
Paranovus Entertainment Technology Ltd through its subsidiary, is engaged in the AI-powered entertainment industry, aiming to provide users with AI-driven games and applications to deliver immersive and engaging entertainment experiences. It is planning to launch SimTwin application which will allow users to interact with digital versions of people and capture life moments. The company also has a software development agreement with Blueline Studios Inc which is developing 10,000 Lives, a mobile game where players pursue various careers and life goals using a board game mechanic.
About ABOS Acumen Pharmaceuticals Inc.
Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease. The company's drug candidate, ACU193, is a subclass monoclonal antibody that selectively targets amyloid-beta oligomers.